Entresto 24mg/26mg, 49mg/51mg and 97mg/103mg film-coated tablets
- Name:
Entresto 24mg/26mg, 49mg/51mg and 97mg/103mg film-coated tablets
- Company:
Novartis Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 05/10/20

Click on this link to Download PDF directly
Novartis Ireland Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 5 October 2020 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 29 September 2020 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 11 August 2020 PIL
Reasons for updating
- Change to other sources of information section
Updated on 8 July 2020 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - what the product looks like and pack contents
- Removal of Black Inverted Triangle
Updated on 8 July 2020 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Removal of Black Inverted Triangle
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 28 November 2019 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 8 - Marketing authorisation number(s)
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 28 November 2019 PIL
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
Updated on 26 November 2019 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 8 April 2019 SPC
Reasons for updating
- File format updated to PDF
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 25 September 2018 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 21 August 2018 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 14 May 2018 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 9 May 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 17 November 2017 PIL
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
Updated on 17 November 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 11 October 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 11 October 2017 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 28 March 2017 SPC
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 27 July 2016 SPC
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Interactions requiring precautions; OATP1B1 and OATP1B3 substrates, e.g. statins
Updated on 14 March 2016 PIL
Reasons for updating
- Introduction of new pack/pack size
Updated on 15 February 2016 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 8 - MA number
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 8: updated to include the new EU numbers corresponding to new pack sizes
Updated on 1 December 2015 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 27 November 2015 PIL
Reasons for updating
- New PIL for new product